Why the study?
The study aimed to explore the preventive effect of low-dose furosemide guided by LVEDP and BNP based on adequate hydration on contrast-induced nephropathy in PCI patients.
Does LVEDP and BNP-guided low-dose furosemide administration reduce the incidence of contrast-induced nephropathy compared to routine low-dose furosemide in patients undergoing PCI with adequate hydration?
Does LVEDP and BNP-guided low-dose furosemide administration reduce the incidence of contrast-induced nephropathy compared to routine low-dose furosemide in patients undergoing PCI with adequate hydration?
LVEDP and BNP-guided low-dose furosemide administration reduces the incidence of contrast-induced nephropathy compared to routine low-dose furosemide in patients undergoing PCI.
Answers are grounded in this paper and cite their sources.
LVEDP/BNP-guided low-dose furosemide may lower CIN after PCI; extends tailored hydration protocols in high-risk patients.
Objective. We aimed to explore the preventive effect of low-dose furosemide administration guided by left ventricular end-diastolic pressure (LVEDP) and B-type natriuretic peptide (BNP) based on adequate hydration on contrast-induced nephropathy (CIN) in patients with percutaneous coronary intervention (PCI). Methods. This parallel randomized clinical trial was conducted at a tertiary hospital in China. A total of 1053 consecutive patients (71.98% men) who underwent PCI at our hospital were enrolled. Pre-PCI plasma BNP levels were recorded. Patients enrolled received a continuous intravenous infusion of normal saline starting 4 h before PCI until 24 h after surgery. LVEDP was measured immediately after surgery. Patients in the control group received intravenous furosemide injection (20 mg). Patients in the experimental group received furosemide if they showed LVEDP ≥15 mmHg, a post-PCI BNP level ≥100 pg/mL, and/or a post-PCI BNP value > 150% of the pre-PCI value. The primary and secondary outcome measures were serum creatinine levels, glomerular filtration rate, and creatinine clearance rate measured before and after PCI. CIN incidence was compared between the two groups. Logistic regression analysis was used to study the risk factors for CIN. Results. CIN incidence was significantly higher in the control group than in the experimental group ( <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mi>P</a:mi> <a:mo><</a:mo> <a:mn>0.05</a:mn> </a:math> ). Logistic regression analysis showed that elevated LVEDP and BNP levels were risk factors. As LVEDP increased, the CIN incidence also increased (odds ratio (OR) 1.038, 95% confidence interval (CI) 1.006–1.070). The OR of BNP was 1.001 (95% CI 1.000–1.002). Conclusions. Low-dose furosemide administration guided by LVEDP or BNP is superior to direct low-dose administration on the basis of adequate hydration during PCI. This trial is registered with ChiCTR-IOR-14005250
No takes yet. Share an insight, caveat, or question.
Gu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: